Wright T C, Castellot J J, Petitou M, Lormeau J C, Choay J, Karnovsky M J
Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115.
J Biol Chem. 1989 Jan 25;264(3):1534-42.
The glycosaminoglycan heparin inhibits the growth of several cell types in vitro including smooth muscle cells and rat cervical epithelial cells. The commercially available heparin which has antiproliferative activity is a structurally heterogeneous polymer that undergoes extensive modifications during maturation. In this report we have performed structure-function studies on heparin's antiproliferative activity using three different cell types: both rat and calf vascular aortic smooth muscle cells and rat cervical epithelial cells. The minimal oligosaccharide size requirements for antiproliferative activity were determined for the three cell types by using oligosaccharide fragments of defined length prepared by nitrous acid cleavage and gel filtration and a synthetic pentasaccharide. The size requirements are similar but not identical for the different cell types. Hexasaccharide fragments are antiproliferative for all three cell types but the synthetic pentasaccharide inhibits the growth of only the rat and calf vascular aortic smooth muscle cells. The interdependence between size and charge for antiproliferative activity was investigated using chemically modified oligosaccharides as well as oligosaccharides prepared from heparin and separated into fractions of differing charge by ion-exchange chromatography. There is a strong interdependence between size and charge for antiproliferative activity. For example, increasing the charge of inactive tetrasaccharide fragments by O-oversulfation makes them antiproliferative whereas reducing the charge of active larger fragments causes them to loose their antiproliferative activity. Finally the importance of 2-O-sulfate glucuronic acid moieties for antiproliferative activity was investigated using heparin preparations that lack 2-O-sulfate glucuronic acid. These compounds possess antiproliferative activity indicating that 2-O-sulfate glucuronic acid is not required for antiproliferative activity.
糖胺聚糖肝素在体外可抑制多种细胞类型的生长,包括平滑肌细胞和大鼠宫颈上皮细胞。具有抗增殖活性的市售肝素是一种结构异质的聚合物,在成熟过程中会经历广泛修饰。在本报告中,我们使用三种不同的细胞类型:大鼠和小牛血管主动脉平滑肌细胞以及大鼠宫颈上皮细胞,对肝素的抗增殖活性进行了结构 - 功能研究。通过使用经亚硝酸裂解和凝胶过滤制备的特定长度的寡糖片段以及一种合成五糖,确定了这三种细胞类型抗增殖活性所需的最小寡糖大小。不同细胞类型的大小要求相似但不完全相同。六糖片段对所有三种细胞类型都具有抗增殖作用,但合成五糖仅抑制大鼠和小牛血管主动脉平滑肌细胞的生长。使用化学修饰的寡糖以及从肝素制备并通过离子交换色谱分离成不同电荷分数的寡糖,研究了抗增殖活性中大小与电荷之间的相互依赖性。抗增殖活性中大小与电荷之间存在很强的相互依赖性。例如,通过O - 过硫酸化增加无活性四糖片段的电荷会使其具有抗增殖作用,而降低活性较大片段的电荷会导致它们失去抗增殖活性。最后,使用缺乏2 - O - 硫酸化葡萄糖醛酸的肝素制剂研究了2 - O - 硫酸化葡萄糖醛酸部分对抗增殖活性的重要性。这些化合物具有抗增殖活性,表明抗增殖活性不需要2 - O - 硫酸化葡萄糖醛酸。